People and Business News 8/23
The latest people and business news from the past month, all in one place.
People News
WCG announced the appointment of Donna Snyder, MD, MBE, as executive physician. Before joining WCG, Snyder earned widespread recognition as an expert in applying scientific and ethical regulations related to the inclusion of children in clinical research and the development of pediatric products.
Phastar revealed the hiring of Graham Clark as its new CEO. Previously, Clark worked as the managing director at Phlexglobal, bringing with him over 25 years of experience in life sciences, financial, and professional services organizations.
Business News
Innovative Trials has been revealed as a finalist in the Lloyd's Bank British Business Excellence Awards. Previously, the company had been named a recipient of the Queen’s Award for international excellence and was named Best Global Patient Recruitment Company in 2021. In a separate press release, the company announced its intention to support funding for a new children’s cancer center at Great Ormond Street Hospital (GOSH) in London, UK.
Calyx announced the successful implementation of its technology by a pharmaceutical company to submit key regulatory information to the FDA during its recently completed electronic common technical document (eCTD) 4.0 implementation pilot program.
ArisGlobal stated its intention to relocate global headquarters to the Boston area. Previously, the company was based out of Miami.
Avance Clinical has been recognized as the recipient of the 2023 Customer Value Leadership Award by Frost & Sullivan. On a yearly basis, Frost & Sullivan presents the award to the company that demonstrates excellence in implementing strategies that proactively create value for its customers, focusing on improving the return on the investment that customers make in its services or products.
CluePoints has announced that its RBQMLive event has won Best Product in the experiential/event marketing category of this year’s Sales and Marketing Technology Awards (Sammys). RBQMLive is an annual event that brings together RBQM experts, clinical trial specialists, and curious listeners to discuss the adoption, utilization, and best practices of risk-based quality management (RBQM), a system for managing data quality throughout a clinical trial across the pharmaceutical sector. The Business Intelligence Group’s awards program is designed to recognize those organizations working to solve the challenges of connecting and collaborating with prospects and customers.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
VERITAC-2 Trial Shows Vepdegestrant Significantly Improves Survival in ESR1-Mutant Breast Cancer
March 24th 2025Phase III VERITAC-2 trial results show vepdegestrant significantly improved progression-free survivalcompared to fulvestrant in patients with ESR1-mutant (ESR1m) advanced or metastatic breast cancer, but did not achieve statistical significance in the overall intent-to-treat population.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
